Gentamicin 80 mg/2 mL Injection BP

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

gentamicin sulfate, Quantity: 40 mg/mL

Available from:

Pfizer (Perth) Pty Ltd

INN (International Name):

gentamicin sulfate

Pharmaceutical form:

Injection, solution

Composition:

Excipient Ingredients: disodium edetate; sulfuric acid; sodium hydroxide; water for injections

Administration route:

Intramuscular, Intravenous

Units in package:

2 mL x 50, 2 mL x 10

Prescription type:

(S1) This Schedule is intentionally blank

Therapeutic indications:

For treatment of infections due to one or more susceptible strains of bacteria, including Pseudomonas aeruginosa, Proteus species (indole positive and indole negative), Escherichia coli, Klebsiella, Enterobacter and Serratia species and Staphylococcus (including strains resistant to other antibiotics). Gentamicin may also be used for the treatment of the following conditions when caused by susceptible organisms: bacteraemia, respiratory tract infections, urinary tract infections, skin and skin structure infections, bone infections, peritonitis, septic abortion and burns complicated by sepsis.

Product summary:

Visual Identification: A clear pale yellow aqueous solution, practically free from visible particles; Container Type: Ampoule; Container Material: LDPE; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Authorization status:

Licence status A

Authorization date:

2016-08-01